Estimation of aluminoxamine and ferrioxamine in plasma by high performance liquid chromatography.
D000535:Aluminum / Q000009:adverse effects / Q000097:blood*; D002851:Chromatography, High Pressure Liquid; D003676:Deferoxamine / Q000097:blood* / Q000627:therapeutic use; D005290:Ferric Compounds / Q000097:blood*; D006801:Humans; D007501:Iron / Q000097:blood*; D007676:Kidney Failure, Chronic / Q000628:therapy; D009942:Organometallic Compounds; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects
D005290:Ferric Compounds; D009942:Organometallic Compounds; C002577:ferrioxamine B; C049544:aluminoxamine; D000535:Aluminum; D007501:Iron; D003676:Deferoxamine